« Anadarko’s Costs Likely To Rise In 2006
Valero Energy Outlook Trimmed »

Biogen Idec’s Tysabri May Return To Market In 2006


J.P. Morgan Securities upgraded the biotech firm to “overweight” from “neutral.”


From www.forbes.com/markets/2005/10/31/biogen-idec-tysabri-1031markets15.html?partner=rss ]]>”>Forbes Market Updates

This entry was posted on Monday, October 31st, 2005 at 8:52 pm and is filed under General updates. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.